InvestorsHub Logo
Followers 17
Posts 2115
Boards Moderated 0
Alias Born 06/18/2007

Re: None

Tuesday, 07/15/2014 9:27:00 AM

Tuesday, July 15, 2014 9:27:00 AM

Post# of 27409
ABC introduced a novel extra corporeal therapy (CytoSorb) to address a unmet need in the critical management of Sepsis.
In keeping with our commitment to introduce innovative therapies, ABC Pharma Services (Pvt ) Ltd and Biocon Ltd were pleased to introduced a novel extra corporeal therapy (CytoSorb) to address a unmet need in the critical management of Sepsis.
The meeting was held at Cinnamon Grand Colombo with the participation of a distinguished gathering of critical care physicians and Anesthesiologists of leading govt and private sector hospitals.
Topic: Sepsis and role of CytoSorb in it.
Speaker: Deepak Govil MD, EDIC, FCCM ( USA)
Associate Director, In charge of Liver Transplant and Gastroenterology ICU- Medan Medicity- New Delhi, India
Accreditation Secretary- Indian College of Critical Medicine.
http://abcpharmasl.com/abc-introduced-novel-extra-corporeal-therapy-cytosorb-address-unmet-need-critical-management-sepsis/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News